OrganoClick
ORGANOCLICK AB (PUBL) PUBLISH INTERIM REPORT FOR Q2 2023
Translation from CEO Mårten Hellbergs comments to the Interim Report.
Q2, 1 April - 30 June 2023
The Group compared with 2022
» Net revenue amounted to SEK 41.03 (38.53) million
» The gross margin amounted to 26.9 (17.6) %
» EBIT amounted to SEK -0.38 (-6.73) million
» Cash-flow from operating activities amounted to SEK 8.04 (-8.52) million
1 January – 30 June 2023
The Group compared with 2022
» Net revenue amounted to SEK 84.51 (71.16) million
» The gross margin amounted to 26.4 (21.1) %
» EBIT amounted to SEK -0.29 (-10.92) million
» Cash-flow from operating activities amounted to SEK -7.18 (-24.87) million
The complete version of the Interim Report is attached in this press release and is available on the companys´ homepage. The informationen in this Interim Report is according to the rules of Nasdaq First North Growth Market.
This disclosure contains information that OrganoClick AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 17-08-2023 08:30 CET.
| Datum | 2023-08-17, kl 08:30 |
| Källa | Cision |
SAVR är investeringsplattformen som utmanar branschen och gör det både enklare och roligare att investera. Betala aldrig för mycket! Alla aktier och ETF:er från 1 kr, och få upp till 50 % rabatt på alla fonder. Automatiskt courtage och samma enkla prismodell på alla marknader.